Masimo (MASI) Return on Capital Employed Growth (1y) (2011 - 2026)
Masimo (MASI) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 658.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 125.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -3,185.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 1,841.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,841.00 |
| Jan 3, 2026 | 1,955.00 |
| Sep 27, 2025 | 17.00 |
| Jun 28, 2025 | -185.00 |
| Mar 29, 2025 | -267.00 |
| Dec 28, 2024 | -395.00 |
| Sep 28, 2024 | -127.00 |
| Jun 29, 2024 | -283.00 |
| Mar 30, 2024 | -306.00 |
| Dec 30, 2023 | -473.00 |
| Sep 30, 2023 | 121.00 |
| Jul 1, 2023 | -108.00 |
| Apr 1, 2023 | -610.00 |
| Dec 31, 2022 | -619.00 |
| Oct 1, 2022 | -876.00 |
| Jul 2, 2022 | -594.00 |
| Apr 2, 2022 | -90.00 |
| Jan 1, 2022 | 39.00 |
| Oct 2, 2021 | 8.00 |
| Jul 3, 2021 | -43.00 |